Logo image of AERC

AEROCLEAN TECHNOLOGIES INC (AERC) Stock Fundamental Analysis

NASDAQ:AERC - Nasdaq - US0077441055 - Common Stock - Currency: USD

3.4  +0.02 (+0.59%)

After market: 3.34 -0.06 (-1.76%)

Fundamental Rating

3

Taking everything into account, AERC scores 3 out of 10 in our fundamental rating. AERC was compared to 40 industry peers in the Building Products industry. While AERC has a great health rating, there are worries on its profitability. AERC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year AERC has reported negative net income.
AERC Yearly Net Income VS EBIT VS OCF VS FCFAERC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -2M -4M -6M -8M

1.2 Ratios

AERC has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AERC Yearly ROA, ROE, ROICAERC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 -5K -10K -15K

1.3 Margins

AERC's Gross Margin of 45.57% is amongst the best of the industry. AERC outperforms 93.48% of its industry peers.
AERC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AERC Yearly Profit, Operating, Gross MarginsAERC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 -200 -400 -600 -800 -1K

8

2. Health

2.1 Basic Checks

AERC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AERC has more shares outstanding
There is no outstanding debt for AERC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AERC Yearly Shares OutstandingAERC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2M 4M 6M 8M 10M
AERC Yearly Total Debt VS Total AssetsAERC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 5M 10M 15M 20M

2.2 Solvency

AERC has an Altman-Z score of 4.42. This indicates that AERC is financially healthy and has little risk of bankruptcy at the moment.
AERC's Altman-Z score of 4.42 is fine compared to the rest of the industry. AERC outperforms 69.57% of its industry peers.
There is no outstanding debt for AERC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.42
ROIC/WACCN/A
WACC9.29%
AERC Yearly LT Debt VS Equity VS FCFAERC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 10M 20M

2.3 Liquidity

AERC has a Current Ratio of 10.20. This indicates that AERC is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 10.20, AERC belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
A Quick Ratio of 9.71 indicates that AERC has no problem at all paying its short term obligations.
AERC has a Quick ratio of 9.71. This is amongst the best in the industry. AERC outperforms 97.83% of its industry peers.
Industry RankSector Rank
Current Ratio 10.2
Quick Ratio 9.71
AERC Yearly Current Assets VS Current LiabilitesAERC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 5M 10M 15M 20M

3

3. Growth

3.1 Past

AERC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -153.81%.
EPS 1Y (TTM)-153.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 10.83% on average over the next years. This is quite good.
The Revenue is expected to grow by 378.04% on average over the next years. This is a very strong growth
EPS Next Y53.52%
EPS Next 2Y33.74%
EPS Next 3Y18.9%
EPS Next 5Y10.83%
Revenue Next Year-44%
Revenue Next 2Y505.53%
Revenue Next 3Y461.06%
Revenue Next 5Y378.04%

3.3 Evolution

AERC Yearly Revenue VS EstimatesAERC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
AERC Yearly EPS VS EstimatesAERC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

AERC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AERC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AERC Price Earnings VS Forward Price EarningsAERC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AERC Per share dataAERC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as AERC's earnings are expected to grow with 18.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.74%
EPS Next 3Y18.9%

0

5. Dividend

5.1 Amount

No dividends for AERC!.
Industry RankSector Rank
Dividend Yield N/A

AEROCLEAN TECHNOLOGIES INC

NASDAQ:AERC (1/11/2023, 8:00:00 PM)

After market: 3.34 -0.06 (-1.76%)

3.4

+0.02 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)11-14 2022-11-14/bmo
Earnings (Next)N/A N/A
Inst Owners0.99%
Inst Owner Change972.06%
Ins Owners15.36%
Ins Owner Change0%
Market Cap52.39M
Analysts82.86
Price Target7.14 (110%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)141%
Min EPS beat(2)-229.77%
Max EPS beat(2)511.77%
EPS beat(4)2
Avg EPS beat(4)57.18%
Min EPS beat(4)-229.77%
Max EPS beat(4)511.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-95.77%
Min Revenue beat(2)-96.18%
Max Revenue beat(2)-95.36%
Revenue beat(4)1
Avg Revenue beat(4)-47.41%
Min Revenue beat(4)-99.56%
Max Revenue beat(4)101.47%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 69.62
P/FCF N/A
P/OCF N/A
P/B 2.21
P/tB 2.21
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.05
BVpS1.54
TBVpS1.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.57%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score0
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.2
Quick Ratio 9.71
Altman-Z 4.42
F-Score0
WACC9.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-153.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y53.52%
EPS Next 2Y33.74%
EPS Next 3Y18.9%
EPS Next 5Y10.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-44%
Revenue Next 2Y505.53%
Revenue Next 3Y461.06%
Revenue Next 5Y378.04%
EBIT growth 1Y-148.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-170.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-153.91%
OCF growth 3YN/A
OCF growth 5YN/A